Analysis of lymphokine-activated killer (LAK) cells.
D000818:Animals; D000943:Antigens, Differentiation / Q000032:analysis; D002277:Carcinoma / Q000628:therapy*; D002454:Cell Differentiation; D002460:Cell Line; D003115:Colony-Stimulating Factors / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007116:Immunization, Passive; D007167:Immunotherapy; D007372:Interferons / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000145:classification / Q000276:immunology*; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D010051:Ovarian Neoplasms / Q000628:therapy*; D013256:Steroids / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D000943:Antigens, Differentiation; D003115:Colony-Stimulating Factors; D013256:Steroids; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons